advertisement

---

Bravetti GE 15

Showing records 1 to 15 | Display all abstracts from Bravetti GE

90162 XEN-augmented Baerveldt drainage device implantation in refractory glaucoma: 1-year outcomes
Bravetti GE
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 1787-1794

---

90295 A Prospective Analysis of iStent Inject Microstent Implantation: Surgical Outcomes, Endothelial Cell Density, and Device Position at 12 Months
Gillmann K
Journal of Glaucoma 2020; 29: 639-647

---

90792 Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors
Gillmann K
Acta Ophthalmologica 2021; 99: e531-e539

---

90295 A Prospective Analysis of iStent Inject Microstent Implantation: Surgical Outcomes, Endothelial Cell Density, and Device Position at 12 Months
Mansouri K
Journal of Glaucoma 2020; 29: 639-647

---

90792 Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors
Bravetti GE
Acta Ophthalmologica 2021; 99: e531-e539

---

90162 XEN-augmented Baerveldt drainage device implantation in refractory glaucoma: 1-year outcomes
Mansouri K
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 1787-1794

---

90792 Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors
Rao HL
Acta Ophthalmologica 2021; 99: e531-e539

---

90162 XEN-augmented Baerveldt drainage device implantation in refractory glaucoma: 1-year outcomes
Gillmann K
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 1787-1794

---

90295 A Prospective Analysis of iStent Inject Microstent Implantation: Surgical Outcomes, Endothelial Cell Density, and Device Position at 12 Months
Ambresin A
Journal of Glaucoma 2020; 29: 639-647

---

90162 XEN-augmented Baerveldt drainage device implantation in refractory glaucoma: 1-year outcomes
Rao HL
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 1787-1794

---

90295 A Prospective Analysis of iStent Inject Microstent Implantation: Surgical Outcomes, Endothelial Cell Density, and Device Position at 12 Months
Bravetti GE
Journal of Glaucoma 2020; 29: 639-647

---

90792 Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors
Mermoud A
Acta Ophthalmologica 2021; 99: e531-e539

---

90295 A Prospective Analysis of iStent Inject Microstent Implantation: Surgical Outcomes, Endothelial Cell Density, and Device Position at 12 Months
Mermoud A
Journal of Glaucoma 2020; 29: 639-647

---

90162 XEN-augmented Baerveldt drainage device implantation in refractory glaucoma: 1-year outcomes
Mermoud A
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 1787-1794

---

90792 Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors
Mansouri K
Acta Ophthalmologica 2021; 99: e531-e539

---